Herein, we showed that in PBMCs of CLL patients, both CTLA-4 and BTLA suppressors were overexpressed at the mRNA level either in the T or B cell subpopulation. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.